Prompt Day #319: Create a “miracle drug” – with one terribly costly side effect
After five years on the market, the FDA announced its intent to pull the drug Conceptulous off the market for further testing. The drug initially marketed as a miracle drug for infertile couples has been pulled after a number of children were born with or developed congenital brain anomalies.
According to Lyon Pharmaceuticals, the makers of the drug, Conceptulous is a natural steroid “amplifier”. Lyon’s rep, Stacey Jillian says “The great thing about Conceptulous, is that it is not an artificial substitute for what your body isn’t making, instead it is a support, a booster in a sense of your body’s own steroids and pre-steroids. Whatever it is you’re lacking in the reproductive hormones, Conceptulous supports the body’s increased production. When you conceive, and you will with Conceptulous, it will be with your body’s own natural processes.”
The problem is, Conceptulous continues to boost and support natural hormones and pre-hormone growth. While many call what is happening to the children conceived on Conceptulous a form of cancers, others specifically in the scientific community say Conceptulous is increasing the speed of natural human evolution. Some babies are born with enlarged brains at birth and as time progresses, their bodies atrophy while their brains continue to grow, orbits enlarge, and all body hair is shed. Others appear normal at birth, but development progresses in the same way.
“My daughter was a perfect 7 pounds 4 ounces at birth. She was our little miracle. But by 16 months, her head was growing so fast that it was stretching her eye sockets and eye lids. Her hair started to fall out. But she was so smart. I mean beyond smart, like rocket science stuff. The things she was building out of old vacuum and toaster parts…we couldn’t believe it. She couldn’t walk yet, but she was reading A Brief History of Time by Stephen Hawking. I don’t know how to feel about Conceptulous. I mean I have a daughter I would never have otherwise, but she will never look normal—not in her own lifetime anyway and I will never be able to relate to her, or think on her level—but think of what she might bring to this world. All the ideas her brain will dream up? How can I be mad?” Maggie Lipson of Fond du Lac, Wisconsin tells us.
Other parents we spoke to who declined to comment echoed the same ambiguity about the drug. At this point, the FDA is requesting all physicians and pharmacies who have prescribed or provided patients with the drug surrender all records and contact information. The FDA is estimating that over 100,000 children may have been affected by the drug. What their future looks like is unclear at the moment, but if Maggie Lipson’s daughter is any indication of what we can expect from those affected, the future may look very different.